amgen glp-1 obesity drug market potential 2025 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 Obesity GLP-1 Market Size to

Huang D, Wang Y, Thompson JW,Yin T, Alexander PB,Qin D,Mudgal P, Wu H,Liang Y

Using the Appetite Visual Analogue Scale and the Eating Inventory in adults with type 2 diabetes, participants receiving retatrutide at doses of 4 mg or higher reported greater reductions in overall appetite, hunger, and prospective food consumption compared with placebo, along with changes in disinhibitiona construct describing loss of control over eating

National Institutes of Health, Office of Dietary Supplements

Immune System & Kidney Support Lower risk of sepsis and other infections, possibly due to reduced oxidative stress and improved immune response